Microsoft EYES Manufacturing WP8 and 4 Dow Drivers in Play Today

Caterpillar Inc. (NYSE:CAT): Brazilian President Dilma Rousseff is stepping up several stimulus projects around the country in order to boost the country’s growth, which has slowed down sharply recently, according to a The New York Times report. However, critics are calling the program ‘an abuse of power by the government’.

Don’t Miss: Noon RISERS: Exxon Mobil Bounces, GE’s Dividend Honors, Merck Very Healthy.

Chevron Corp. (NYSE:CVX) and McMoRan Exploration (NYSE:MMR) jointly made eight of the winning high bids in the Central Gulf of Mexico Lease Sale conducted by the Bureau of Ocean Energy Management on June 20th. McMoRan was solely the high bidder on a total of six lease blocks on the outer Continental Shelf of the Gulf of Mexico. McMoRan will pay about $3.1 million in bonuses for the leases, once the bidding process is officially approved by the BOEM, which should add over 65,000 gross acres to McMoRan’s leasehold inventory, which is around 900,000 gross acres as it now stands, including over 200,000 gross acres tied to the shallow water, ultra-deep plays.

Walt Disney Co. (NYSE:DIS): NBC’s (NASDAQ:CMCSA) “Today” show, for the first time in 16 years, is no longer Number One in the ratings. NBC News has other ratings problems, such as the Sunday talk shows and the evening news, says the Wall Street Journal.

Johnson & Johnson’s (NYSE:JNJ) Janssen division reported Thursday night that the FDA has provided a complete response letter regarding a supplemental New Drug Application for Xarelto for the reduction of the risk of secondary cardiovascular events in patients suffering from acute coronary syndrome. The letter is being evaluated and Janssen will respond to any questions the agency might have. The drug has been approved for three clinical uses in the U.S., namely, to decrease the risk of blood clots in the legs and lungs of people who have just had knee replacement surgery, in people who have just had hip replacement surgery, and to reduce the risk of both hemorrhagic and thrombotic strokes, as well as other blood clots in patients with atrial fibrillation that is not caused by a heart valve problem.

Microsoft Corporation (NASDAQ:MSFT) could be partnering with a contract manufacturer to develop its own handset for Windows Phone 8, says Reuters, referring to a Nomura analyst’s note to investors on Thursday that cited checks with industry sources.

Don’t Miss: Will Microsoft’s Surface Be DEAD ON ARRIVAL?

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.